Guangdong Zhongsheng Pharmaceutical Co., Ltd. Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

002317

Classificação em ações #4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Preço da ação
$3.89
Valor de mercado
$3.30B
Variação (1 dia)
-3.14%
Variação (1 ano)
43.11%
País
CN
Negociar Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)

Categoria

Healthcare
Receita da Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Receita em Jun 2026 TTM: $332.95M
De acordo com os últimos relatórios financeiros da Guangdong Zhongsheng Pharmaceutical Co., Ltd., a receita atual da empresa (TTM) é $332.95M. Em 2024, a empresa obteve uma receita de $338.04M uma diminuição em relação a a receita do ano 2023, que foi de $368.79M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Guangdong Zhongsheng Pharmaceutical Co., Ltd. de 2006 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $332.95M -7.66%
2025 $360.58M 6.67%
2024 $338.04M -8.34%
2023 $368.79M -4.94%
2022 $387.97M 1.51%
2021 $382.18M 31.69%
2020 $290.21M -20.17%
2019 $363.55M 5.90%
2018 $343.31M 13.72%
2017 $301.90M 23.85%
2016 $243.77M 0.33%
2015 $242.96M 15.01%
2014 $211.26M 17.56%
2013 $179.70M 26.42%
2012 $142.15M 19.38%
2011 $119.07M 22.66%
2010 $97.07M 20.15%
2009 $80.79M 13.84%
2008 $70.98M 28.15%
2007 $55.38M 32.26%
2006 $41.88M 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$23.54B 6,968.81%
DE
$23.73B 7,028.77%
DE
$29.24B 8,682.09%
JP
$5.85B 1,656.66%
CH
$6.34B 1,804.89%
IN